Residency · Residency · Interventional Radiology

Complications in IR: Recognition and Management

Introduction

Interventional radiology procedures, while minimally invasive, carry inherent risks of complications. Early recognition, prompt management, and transparent reporting are the hallmarks of a safe IR practice. Understanding the classification, prevention, and management of complications is essential for every IR trainee and practitioner.

SIR Adverse Event Classification

By Severity

SIR ClassSeverityDescription
AMinorNo therapy required; no consequence
BMinorNominal therapy, no consequence; includes overnight observation
CMajorRequires therapy, minor hospitalization (<48 hours)
DMajorMajor therapy, extended hospitalization or ICU admission
EMajorPermanent adverse sequelae
FMajorDeath

Minor complications: require no therapy (A) or nominal therapy with no consequence (B); includes overnight admission for observation. Major complications: require therapy with minor hospitalization (< 48 hours) (C), major therapy with extended hospitalization or ICU (D), permanent adverse sequelae (E), or death (F). This classification system facilitates standardized quality reporting and benchmarking.

By Timing

Immediate: during or within 24 hours of the procedure. Early: 1-30 days post-procedure. Late: beyond 30 days.

Vascular Complications

Access Site

Hematoma: most common; manage with manual compression; large hematomas may require surgical evacuation. Pseudoaneurysm: pulsatile mass at access site; diagnosed with ultrasound; treat with ultrasound-guided thrombin injection (90-95% success) or covered stent if large. Arteriovenous fistula: continuous bruit at access site; most resolve spontaneously; may require covered stent or surgical repair. Retroperitoneal hemorrhage: from high femoral puncture above the inguinal ligament; presents with flank pain, hypotension, falling hemoglobin; CTA to diagnose; may require embolization or surgery.

Vessel Injury

Dissection: intimal flap creation from catheter or wire manipulation; manage with stent placement if flow-limiting. Perforation/Rupture: acute extravasation; manage with balloon tamponade, covered stent, or surgical repair. Thrombosis: in-situ clot formation; treat with aspiration thrombectomy, thrombolysis, or surgical thrombectomy. Embolization (non-target): embolic material reaching unintended vessels; consequences depend on end-organ.

Non-Vascular Complications

Infection

Abscess: at the procedure site or in targeted organs; managed with antibiotics and drainage. Bacteremia/Sepsis: from manipulation of infected fluid collections or contaminated biliary/urinary systems; prophylactic antibiotics reduce risk. Device infection: tunneled catheters, ports, stents; may require device removal and antibiotics.

Organ Injury

Pneumothorax: from lung biopsy, thoracic procedures, or central line placement; small pneumothorax may observe; large or symptomatic requires chest tube. Bowel perforation: from percutaneous abdominal procedures; present with peritonitis; may require surgical repair. Non-target organ infarction: from embolization procedures; minimize with superselective technique.

Contrast-Related

Allergic reaction: urticaria (mild) to anaphylaxis (severe); treat per severity (diphenhydramine, epinephrine, steroids). Contrast-induced nephropathy (CIN): rise in creatinine > 0.5 mg/dL or 25% from baseline within 48-72 hours; prevent with hydration, minimize contrast volume, avoid nephrotoxins. Contrast extravasation: subcutaneous infiltration of contrast from IV; warm compresses, elevation; compartment syndrome is rare but serious.

Procedure-Specific Complications

Biliary Interventions

Cholangitis: from biliary manipulation; pre-procedural antibiotics and adequate drainage reduce risk. Bile leak/biloma: from transgression of the biliary system; manage with percutaneous drainage. Hemobilia: from hepatic artery-biliary fistula; may require embolization.

Embolization Procedures

Post-embolization syndrome: fever, pain, nausea, leukocytosis; expected after uterine, hepatic, and splenic embolization; self-limited; manage with NSAIDs and antiemetics. Non-target embolization: the most feared complication; prevent with meticulous catheter positioning and angiographic evaluation. Organ failure: hepatic failure after TACE, renal failure after renal embolization; risk stratification is critical.

Drainage Procedures

Catheter dislodgement: secure catheters with locking pigtail, suture, or adhesive device. Drain occlusion: from viscous fluid or debris; flush and exchange as needed. Fistula formation: persistent communication between drained cavity and adjacent structures.

Prevention Strategies

Preprocedural planning: review imaging, assess coagulation, optimize patient. Technique: meticulous catheter and wire handling, fluoroscopic/ultrasound guidance, superselective embolization. Checklists and timeouts: standardized verification of patient, procedure, site, and equipment. Antibiotic prophylaxis: per SIR guidelines for specific procedures (biliary, genitourinary, device implantation). Post-procedural monitoring: appropriate observation period; clear discharge criteria.

Complication Reporting and Quality Improvement

Morbidity and mortality (M&M) conferences: regular review of adverse events in a non-punitive environment. SIR quality improvement guidelines: published complication thresholds for common procedures. Root cause analysis: for serious adverse events to identify system and process failures. NSQIP and institutional databases: track outcomes for benchmarking and improvement. Culture of transparency and learning rather than blame.

Emergency Management

Massive hemorrhage: activate massive transfusion protocol; obtain hemostasis (balloon tamponade, covered stent, embolization). Anaphylaxis: epinephrine 0.3-0.5 mg IM (first line); IV access, fluids, steroids, H1/H2 blockers. Cardiac arrest: initiate ACLS; defibrillation for shockable rhythms; document and debrief. Tension pneumothorax: immediate needle decompression followed by chest tube. Emergency equipment must be checked daily and immediately accessible in every IR suite.

Key Clinical Pearls

SIR adverse event classification (A-F) provides a standardized framework for complication reporting and quality improvement. Ultrasound-guided thrombin injection is first-line for femoral pseudoaneurysms with a success rate exceeding 90%. Post-embolization syndrome is an expected outcome, not a complication; educate patients preoperatively. Prevention through meticulous preprocedural planning, intra-procedural technique, and post-procedural monitoring is the best complication management. A culture of transparent reporting and non-punitive M&M conferences drives continuous improvement.

References

  1. Defined the Core Practice Standards. Defined Core Practice. Sacks D, McClenny TE, Cardella JF, Lewis CA. SIR Clinical Practice Guidelines for Quality Improvement. JVIR. 2003;14(9 Pt 2):S199-S202.
  2. Defined the Core Practice Guidelines. Defined Core Practice. Defined Core Clinical Practice. Defined Core Competencies. Defined Core Practice Guidelines. Defined Core Updates. ACR-SIR Practice Parameter for Reporting Complications. 2020.
  3. Defined the Core Practice Standards. Defined Core Practice. Defined Core Clinical Practice. Defined Core Competencies. Defined Core Practice Guidelines. Defined Core Updates. Defined Core Clinical Practice Standards. JVIR Quality Improvement Guidelines. 2019.
  4. Defined the Core Practice Standards. Defined Core Practice. Defined Core Clinical Practice. Defined Core Competencies. Defined Core Practice Guidelines. Defined Core Updates. ACR Contrast Manual v2023. 2023.

Read this lecture as Markdown